Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

40
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
40
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

693
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
693
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

1.9K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.9K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

2.0K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.0K
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

257
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
257
Hormonal Regulation01:33

Hormonal Regulation

32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Continuous carbon dioxide flow via a modified 4-way stopcock to prevent hemostatic spray catheter clogging.

VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy·2026
Same author

Intracardiac Thrombi in Behçet's Disease: Systematic Review of 218 Patients' Clinical Characteristics and Treatments.

European cardiology·2026
Same author

Incidental Tentorial Cerebelli Hypoplasia: A Case Report and Comprehensive Literature Review of Its Clinical and Imaging Characteristics.

Case reports in medicine·2026
Same author

Gender differences in symptoms suggestive of diabetic gastroparesis in the West Bank: clinical insights from a cross-sectional study.

Frontiers in medicine·2026
Same author

Efficacy and safety of orforglipron in obesity with type 2 diabetes mellitus: a GRADE-assessed meta-analysis of randomized controlled trials.

Diabetology & metabolic syndrome·2026
Same author

Baseline TRI-SCORE for risk stratification before tricuspid transcatheter edge-to-edge repair: A systematic review and meta-analysis.

Cardiovascular revascularization medicine : including molecular interventions·2026

Related Experiment Video

Updated: May 23, 2025

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

20.3K

Hyperuricemia and Cardiovascular Risk: Insights and Implications.

Abdalhakim Shubietah1, Ameer Awashra2, Fathi Milhem2

  • 1From the Department of Internal Medicine, Advocate Illinois Masonic Medical Center, Chicago, IL.

Critical Pathways in Cardiology
|March 10, 2025
PubMed
Summary
This summary is machine-generated.

Elevated uric acid (hyperuricemia) is linked to cardiovascular diseases, but its exact role and the benefits of urate-lowering therapies remain complex and require personalized treatment strategies.

Keywords:
atherosclerosiscardiovascular riskendothelial dysfunctionhypertensionhyperuricemiauric acidxanthine oxidase

More Related Videos

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
08:21

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations

Published on: July 21, 2023

1.2K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.5K

Related Experiment Videos

Last Updated: May 23, 2025

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

20.3K
Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
08:21

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations

Published on: July 21, 2023

1.2K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.5K

Area of Science:

  • Cardiology and Nephrology
  • Metabolic Disorders

Background:

  • Hyperuricemia, defined by elevated serum uric acid, is increasingly prevalent globally.
  • It is associated with multiple cardiovascular diseases, including hypertension, heart failure, and coronary artery disease.
  • Mechanisms linking hyperuricemia to cardiovascular risk involve inflammation, oxidative stress, and endothelial dysfunction.

Purpose of the Study:

  • To review the complex relationship between hyperuricemia and cardiovascular diseases.
  • To evaluate the role of urate-lowering therapies in managing cardiovascular risk.
  • To discuss the implications for clinical practice and future research directions.

Main Methods:

  • Comprehensive literature review of major cardiovascular and hyperuricemia studies (e.g., Framingham Heart Study, CARES, FAST).
  • Analysis of mechanisms linking elevated uric acid to cardiovascular pathology.
  • Examination of evidence for urate-lowering therapies and conflicting trial results.

Main Results:

  • Hyperuricemia is associated with increased cardiovascular risk, mediated by inflammation and endothelial dysfunction.
  • Conflicting evidence exists regarding the cardiovascular benefits and safety of urate-lowering therapies (e.g., febuxostat vs. allopurinol).
  • The causal role of hyperuricemia versus its function as a risk marker is still debated.

Conclusions:

  • Clinical management of hyperuricemia in cardiovascular disease requires individualized risk assessment.
  • Further research is needed to clarify hyperuricemia's causal role and optimize treatment strategies.
  • Integrating uric acid levels into cardiovascular risk scores may improve patient stratification.